NTRA NTRA
Company Profile ↓Company Overview
NTRA (NTRA) is a publicly traded company listed on with a market capitalization of $38.36B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 40.4% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.13.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $2.31B (+35.9% YoY); net profit $-208.16M.
- Trailing 12 Months Year-on-year growth — revenue +35.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 40.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 40.40% |
| 1 Year: | 35.90% |
Stock Price Performance
| 1 Year: | +101.08% |
| 6 Months: | +20.62% |
| 3 Months: | +32.81% |
| 1 Month: | -2.36% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)60.03 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 40.4% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 49.38M | 52.28M | 55.91M | 52.05M | 62.34M | 63.07M | 65.28M | 66.97M | 66.82M | 74.36M | 77.91M | 83.24M | 94.01M | 86.47M | 98.14M | 152.32M | 142.03M | 158.12M | 194.13M | 198.20M | 210.64M | 241.76M | 261.40M | 268.31M | 367.74M | 413.35M | 439.76M | 501.83M | 546.60M | 592.18M | 665.50M | 696.64M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 185.06M | 200.00M | 207.80M | 220.07M | 245.81M |
| Gross Profit | 22.59M | 19.36M | 14.46M | 21.10M | 29.56M | 21.01M | 19.63M | 11.30M | 15.68M | 17.72M | 21.30M | 15.32M | 21.75M | 22.07M | 23.60M | 24.18M | 23.52M | 30.53M | 34.03M | 38.78M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 316.76M | 346.60M | 384.38M | 445.43M | 450.83M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 395.94M | 456.98M | 481.96M | 468.21M | 544.35M |
| Operating Income | -6.28M | -15.47M | -20.74M | - | -9.61M | -22.52M | -26.66M | - | -34.55M | -28.37M | -25.79M | - | -30.52M | -27.22M | -27.17M | - | -31.75M | -28.64M | -21.09M | - | -34.87M | -51.66M | -55.78M | -63.02M | -115.29M | -150.20M | -137.13M | -143.09M | -119.05M | -138.30M | -112.43M | -110.98M | -74.31M | -43.90M | -39.34M | -79.18M | -110.37M | -97.58M | -22.79M | -93.52M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -56.52M | -89.78M | -76.00M | 1.76M | -63.69M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00M | 1.03M | 1.04M | 991.00K | 892.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -66.76M | -100.66M | -87.34M | -13.33M | -84.81M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 173.00K | 275.00K | 207.00K | -60.58M | 283.00K |
| Net Income | -10.00M | -19.68M | -17.63M | -22.96M | -8.69M | -23.16M | -26.02M | -37.91M | -33.48M | -29.07M | -27.86M | -47.22M | -32.87M | -33.82M | -29.62M | -31.84M | -34.09M | -32.42M | -23.14M | -35.18M | -35.37M | -59.64M | -58.32M | -63.85M | -116.03M | -151.27M | -138.59M | -145.15M | -121.48M | -136.94M | -110.80M | -109.03M | -67.60M | -37.46M | -31.59M | -66.94M | -100.94M | -87.54M | 47.26M | -85.09M |
| Diluted EPS | - | - | -0.39 | - | -0.17 | -0.46 | -0.50 | -0.72 | -0.65 | -0.55 | -0.52 | -0.90 | -0.61 | -0.62 | -0.49 | -0.51 | -0.54 | -0.48 | -0.33 | -0.46 | - | - | - | -0.74 | -1.32 | -1.63 | -1.45 | -1.50 | -1.25 | -1.23 | -0.97 | -0.95 | -0.56 | -0.30 | -0.26 | -0.50 | -0.74 | -0.64 | - | -0.60 |
| R&D Expense | 5.63M | 6.74M | 7.34M | - | 8.76M | 10.30M | 11.35M | - | 12.65M | 11.79M | 12.61M | - | 14.34M | 11.85M | 12.39M | - | 11.44M | 12.12M | 12.80M | - | 18.23M | 23.00M | 26.42M | 40.19M | 53.75M | 98.46M | 80.41M | 82.58M | 65.51M | 82.31M | 78.17M | 77.23M | 88.64M | 89.11M | 96.93M | 129.08M | 146.43M | 173.41M | - | 210.70M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55.17M | 159.29M | 190.35M | 212.51M | 209.62M | 257.65M | 302.33M | 391.00M | - | 820.22M | 1.08B | 1.70B | 2.31B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | 456.26M | 589.83M | 673.75M | 812.93M |
| Gross Profit | - | - | - | - | - | - | - | - | - | 363.97M | 492.74M | 1.02B | 1.49B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | 905.01M | 938.99M | 1.25B | 1.80B |
| Operating Income | -25.27M | 665.00K | -59.84M | -101.05M | -135.34M | -114.63M | -116.29M | -216.28M | - | -541.04M | -446.25M | -222.29M | -309.91M |
| EBITDA | - | - | - | - | - | - | - | - | - | -520.80M | -397.80M | -148.08M | -220.54M |
| Interest Expense | - | - | - | - | - | - | - | - | - | 9.32M | 12.64M | 10.69M | 4.07M |
| Pretax Income | - | - | - | - | - | - | - | - | - | -546.82M | -434.53M | -189.73M | -268.09M |
| Tax Provision | - | - | - | - | - | - | - | - | - | 978.00K | 271.00K | 695.00K | -59.93M |
| Net Income | -37.11M | -5.15M | -70.28M | -100.33M | -137.63M | -128.15M | -124.83M | -229.74M | - | -547.80M | -434.80M | -190.43M | -208.16M |
| Diluted EPS | - | - | -2.68 | -1.95 | -2.59 | -2.22 | -1.79 | -2.84 | - | -5.57 | -3.78 | -1.53 | -1.52 |
| R&D Expense | 11.55M | 17.29M | 27.71M | 41.86M | 50.06M | 51.35M | 51.36M | 100.03M | 264.21M | 316.42M | 320.68M | 404.14M | 624.11M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 123.62M | 265.24M | 210.68M | 214.61M | 268.17M | 582.66M | 932.15M | - | 1.39B | 1.44B | 1.66B | 2.40B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | 1.21B | 1.26B | 1.38B | 1.50B |
| Cash & Equivalents | 5.75M | 30.50M | 87.18M | 28.95M | 15.26M | 12.62M | 46.41M | 61.93M | 48.67M | - | 466.09M | 642.10M | 945.59M | 1.08B |
| Inventory | - | - | - | - | - | - | - | - | - | - | 35.41M | 40.76M | 44.74M | 68.44M |
| Receivables | - | - | - | - | - | - | - | - | - | - | 244.38M | 278.29M | 314.17M | 296.53M |
| Total Liabilities | - | - | 54.35M | 80.47M | 104.20M | 189.20M | 236.01M | 303.94M | 445.92M | - | 688.73M | 676.37M | 465.31M | 685.93M |
| Current Liabilities | - | - | 29.87M | 80.47M | 96.42M | 105.56M | 113.98M | 179.87M | 199.05M | - | 310.50M | 307.27M | 344.05M | 441.23M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | 280.39M | 281.65M | 282.94M | - | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - | 446.22M | 441.99M | 187.12M | 214.38M |
| Total Equity | -136.31M | -171.51M | -171.34M | 226.43M | 143.58M | 25.42M | 32.16M | 278.71M | 486.24M | - | 705.74M | 765.33M | 1.20B | 1.71B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 111.25M | 119.58M | 132.65M | 139.69M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | -37.83M | -74.05M | -97.83M | -70.58M | -63.44M | -182.51M | - | -431.50M | -246.96M | 135.66M | 215.30M |
| Investing Cash Flow | - | - | -210.68M | 47.03M | 13.78M | -5.16M | -266.35M | -331.46M | - | 330.34M | 168.50M | 137.62M | -132.21M |
| Financing Cash Flow | - | - | 190.28M | 13.18M | 80.37M | 113.72M | 340.77M | 500.85M | - | 482.64M | 254.46M | 30.20M | 47.46M |
| Capital Expenditure | -8.24M | -9.96M | -7.85M | -23.14M | -9.87M | -3.88M | -4.97M | -19.60M | - | -47.70M | -39.20M | -76.92M | -139.19M |
| Free Cash Flow | - | - | -45.68M | -97.19M | -107.69M | -74.46M | -68.41M | -202.12M | - | -479.20M | -286.15M | 58.75M | 76.11M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | 381.48M | 176.00M | 303.49M | 130.55M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | 44.4% | 45.5% | 60.3% | 64.7% |
| Operating Margin % | -45.8% | 0.4% | -31.4% | -47.6% | -64.6% | -44.5% | -38.5% | -55.3% | - | -66.0% | -41.2% | -13.1% | -13.4% |
| Net Margin % | -67.3% | -3.2% | -36.9% | -47.2% | -65.7% | -49.7% | -41.3% | -58.8% | - | -66.8% | -40.2% | -11.2% | -9.0% |
| ROE % | 21.6% | 3.0% | -31.0% | -69.9% | -541.5% | -398.5% | -44.8% | -47.2% | - | -77.6% | -56.8% | -15.9% | -12.2% |
| ROCE % | - | 0.7% | -32.4% | -88.4% | -124.1% | -74.3% | -28.9% | -29.5% | - | -49.9% | -39.3% | -16.9% | -15.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NTRA
After U.S. approval, Natera submits bladder cancer test in Japan - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNcWY4ckRSNTNFQ21PWjlTQjU5OTNuSnh6UFZVQWhENjBQUjk2RTltYVBPRHBFUmxkUjl0eE9OT0JOcEZRem1mWkZrUDFpcGpRX1pmMHpUYlpxMUdXTWxvcDNzbVR0UC1iUXh3R2dSbjFWTlVpSHpnUWgwNXFjTDVIMkJIWFBVT2RiaDJOS1…
Natera (NTRA) Stock Looks Overvalued Despite Strong Signatera Optimism - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQMWM1SjlUM0ZxZWMtdUtONWhVSEN4NG9RLW95VEhXZTR0c2tEa1NvLThtREswMElQb3NtOG5RdTJEN2RVNGYtRVlmOUhLUjg0REpqRjFnX21nVFF6QkhvNWNBeUFGRTQtclBVc1RuWnI4QjREczI4cWRmU1NvUlNKWTd5NTIzNGwxNmhRUC…
Natera (NTRA) Stock Trades At A Premium To Sales After A 425% Return - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNRHNGMU9IazhvMVhsZzhTMVlWd2lDTGp5ZklobklGZ21lSjUyNU9IeVY3MWhIMkN4ZGFGUUx5QVBvS3Q1aDBONkJqQ3dVUVl5Wl9GU0lfYWxKUjkzNVpuX3IxdzNrY2Vxd2ttdEFKN1lyNG5qUTNvQnJxRExHSFk1RkZDVUM2dU1icllyMm…
Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings - StockStory
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPZjJZQnphTkFhdW9kSVlEOGtNZkZnb1J0bnRaeVYyQmVHRU11RWJqdG5OcVNCMlViMWJuRk1qSnJJeHhtM0JvRmt3NlFabTFXTWg0WXlJa2dINElsd20yY2hnRFZmdVJ1TDdRLVRmTG82NmpUQzVuYlhxaFRia1B0WWJkS1doWTJEYll6TU…
Natera (NTRA) Sets Earnings Date, Is The Stock Fully Priced? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOWHFMN1lXOHNycDVTelg3QVRtcDdFYkJVN2lUcmVQblNzdUV4emtpTEhfU0NiNGxObEtnd2ZaODZCY3pqellFd2tEXzgwcmk0X0Zlbk93WHRDT0VSTEZ6Yzl3emVzMERjVUdjekdiYmlaMThrb2J0VzJxS1VteGwxRkVkZTA4MGNKX2U1TT…
NTRA (NASDAQ: NTRA) plans sale of common stock holdings - Stock Titan
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNM0QtZTNEZ0M3dlF6ZlBhdTJ5OVgwNlFKZWpJX0dyV0lObHNRSEs2OEk3WTA5M1kxV2FQTEh6WHh2TE9qam5uem84Um5ZZEFBam5pTlBrZWgyMHV0T0NNU2UyYnhWd2tvOW83YXF2UFAwUVNKQWM2S2twcmNLSUVXMkhQZ192UVpma2Fua0…
NTRA — Frequently Asked Questions
What is the current share price of NTRA?
As of 2026-08-05 17:25 PDT, NTRA trades at $274.62 on NASDAQ/NYSE. Its 52-week range is $136.57 to $283.80.
What is the market capitalisation of NTRA?
NTRA has a market capitalisation of $38.36B on NASDAQ/NYSE.
What is the P/E ratio of NTRA?
NTRA trades at a trailing price-to-earnings (P/E) ratio of -180.67. Its price-to-book (P/B) ratio is 22.40.
What is the return on equity (ROE) of NTRA?
NTRA has a return on equity (ROE) of -12.16%. Its return on capital employed (ROCE) is -15.84%.
Is NTRA a good stock to buy?
This page provides a data-driven analysis of NTRA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.